Neurology Investment Portfolios

Silo Pharma Sets Its Sights on 2024 with Focus on Mental Health, Chronic Pain, and Neurological Disorders Feb 2, 2024

Vico Therapeutics Secures $60 Million Series B Funding for Neurological Disease Program Jan 6, 2024